Riskpilot← Back to searchSign inGet full accessTomas Ohrlander Läkarkonsult AB
ABActiveOrg 5569798977Porsvägen 10Hospital activities · NACE 8610Est. 20140 employees
Revenue 2024
SEK 885K
-11% vs 2023
EBITDA margin
95.3%
+7% vs 2023
Equity ratio
63.9%
Financial strength
Net profit 2024
SEK 585K
+11% vs 2023
| Revenue | SEK 885K | -11% |
| EBITDA | SEK 843K | +7% |
| Net profit | SEK 585K | +11% |
| Total assets | SEK 3,1M | +51% |
| Equity | SEK 2M | +42% |
| Employees | 0 | — |
Legal name
Tomas Ohrlander Läkarkonsult AB
Org number
5569798977
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
19 augusti 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkarkonsultationer och därmed förenlig verksamhet.
Address
Porsvägen 10
Email
tomas.ohrlander@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 590 | 470 | 560 | 991 | 885 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 321 | 189 | 330 | 791 | 843 |
| Depreciation & amort. | −100 | −105 | −19 | −33 | −29 |
| EBIT | 221 | 84 | 311 | 758 | 814 |
| Net financials | −13 | −11 | −0 | 6 | 6 |
| Profit before tax | 334 | 74 | 300 | 664 | 741 |
| Tax | −72 | −16 | −64 | −138 | −155 |
| Net profit | 262 | 58 | 236 | 526 | 585 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 027 | 1 988 | 1 787 | 2 036 | 3 083 |
| Equity | 1 130 | 1 004 | 1 053 | 1 383 | 1 968 |
| Long-term debt | 299 | 247 | 0 | — | 407 |
| Short-term debt | 189 | 327 | 314 | 133 | 107 |
| Total debt | 488 | 574 | 314 | 133 | 514 |
EBITDA margin
95.3%
This company
15.8%
Market median
+503% vs market
20202024
Equity ratio
63.9%
This company
38.2%
Market median
+67% vs market
20202024
Return on equity
29.7%
This company
18.4%
Market median
+61% vs market
20202024
Net profit margin
66.1%
This company
8.1%
Market median
+716% vs market
20202024
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20202024
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tomas Ohrlander Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Gustav Tomas Ohrlander | Deputy Board Member | 0 companies |
| Jan Tomas Ohrlander | Board of Directors | 0 companies |
| Camilla Héléne Thérése Nilsson | Deputy Board Member | 0 companies |
| Carl Ludvig Emil Ohrlander | Deputy Board Member | 0 companies |